实验方法>
细胞技术>
前沿科技及其它>Phospho-Specific Antibodies as a Tool to Study In Vivo Regulation of BRCA1 After DNA Damage
Phospho-Specific Antibodies as a Tool to Study In Vivo Regulation of BRCA1 After DNA Damage
关键词: phospho-specific phospho来源: 互联网
Phospho-specific antibodies have become very useful reagents for study of signal transduction pathways. This chapter describes the production of phospho-specific antibodies and their use to assess individual phosphorylation events in vivo in cells. The first step involves the synthesis of peptides (12–15 residues), where the phosphorylation site is centrally located, and a cysteine residue is incorporated at either the N- or C-terminus of the peptide to facilitate coupling it to an immunogenic carrier protein. No special immunization protocols are required to generate phospho-specific antibodies. Typically, animals of choice are immunized twice, several weeks apart, and enzyme-linked immunosorbent assay is used to determine the relative titer of sera against phosphorylated and nonphosphorylated peptides. Where the titer against phosphorylated peptides is much greater than nonphosphorylated peptides, the sera can be used at appropriate dilutions without further processing. In case a significant level of antibodies specific to the nonphosphorylated peptide is present in the antisera, an enhancement step is used to obtain a useful phospho-specific antibody. Although these enhanced antisera are suitable for many applications, there may be circumstances where affinity-purified antibodies are required. These antibodies can be used to detect a particular phosphorylation event in vivo using Western blotting, immunoprecipitation, and immunofluorescence.
推荐方法
- Multidrug Resistance in Cancer
- Detection of K-ras Mutations by a Microelectronic DNA Chip
- Pathology of Kidney Tumors
- Hereditary Colon Cancer Genes
- Purification of the Mitotic Checkpoint Complex, an Inhibitor of the APC/C From HeLa Cells
- On-Demand Cleavable Linkers for Radioimmunotherapy
- 外源基因在真核细胞表达技术
- 干细胞(Stem cell)
- Clinical Protocol for p53 Gene Therapy for Liver Tumors
- Flow Cytometric Monitoring of Fluorescent Drug Retention and Efflux